Latest Share Chat

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares

Wed, 16th Dec 2020 09:21

(Alliance News) - Scancell Holdings PLC said on Wednesday that an investment vehicle of Non-Executive Director Martin Diggle bought 750,000 shares.

Vulpes Life Sciences Fund paid 10.5 pence per share in a single transaction, worth GBP78,750. Diggle's Vuples now holds a 14.5% stake in Scancell, which develops immunotherapies for the treatment of cancer.

Scancell shares were up 6.9% at 11.49 pence in London on Wednesday.

By Zoe Wickens; zoewickens@alliancenews.com

Related Shares

More News

26 Mar 2024 14:00

Scancell doses first patient in melanoma-focused trials

(Alliance News) - Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic....

5 Feb 2024 14:09

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

30 Jan 2024 13:56

Scancell interim loss narrows amid finance gain on derivative

(Alliance News) - Scancell Holdings PLC on Tuesday reported a narrowed loss as it gained on the revaluation of derivative liability.

17 Jan 2024 14:26

IN BRIEF: Scancell approved by MHRA to add new cohort to Scope trial

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease said - Receives approval fro...

19 Dec 2023 13:35

Scancell raises GBP12 million in total from fundraise

(Alliance News) - Scancell Holdings PLC on Tuesday said it has raised GBP11.9 million in total, from an open offer, placing, and subscription of share...